SIETES :: 92565 citas

Resultados de la búsqueda por GRIPE REFINAR BÚSQUEDA

1.

Anónimo. Recommended composition of influenza virus vaccines for use in the 2018-2019 Northern hemisphere influenza season. World Health Organization 2018:22 de febrero. [Ref.ID 102540]

2.

Wise J. Trivalent flu vaccine won’t protect against influenza B strain predominantly circulating. BMJ 2018;360:k78. [Ref.ID 102448]

3.

Anónimo. Health officials predict rough flu season, point to potentially less effective vaccine. DIA Daily 2017:17. [Ref.ID 102161]

4.

Zost SJ, Parkhouse K, Gumina ME, Kim K, Díaz Pérez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains . Proceedings of the National Academy of Sciences of the United States of America 2017:6 de noviembre. [Ref.ID 102123]

5.

Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, Cheetham TC, Glanz JM, Jackson LA, Klein NP, Naleway AL, Weintraub E, Belongia EA. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12. Vaccine 2017;35:5314-22. [Ref.ID 102049]

6.

Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]

7.

Graner S, Svensson T, Beau A-B, Damase-Michel C, Engeland A, Furu K, Hviid A, Haberg SE, Molgaard-Nielsen D, Pasternak B, Kieler H. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study. BMJ 2017;356:j629. [Ref.ID 101465]

8.

Anónimo. Influenza vaccine for 2016-2017. Med Lett Drugs Ther 2016;58:127-30. [Ref.ID 100884]

9.

Chahal JS, Khan OF, Cooper CL, McPartlan JS, Tsosie JK, Tilley LD, Sidik SM, Lourido S, Langer R, Bavari S, Ploegh HL, Anderson DG. Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose. Proceedings of the National Academy of Sciences of the United States of America 2016;113:E4133-42. [Ref.ID 100595]

10.

Hawkes N. UK stands by nasal flu vaccine for children as US doctors are told to stop using it. BMJ 2016;353:i3546. [Ref.ID 100450]

11.

Hawkes N. Sixty seconds on . . . Tamiflu. BMJ 2016;353:i3064. [Ref.ID 100384]

12.

Ludvigsson JF, Ström P, Lundholm C, Cnattingius S, Ekbom A, Órtqvist A, Feltelius N, Granath F, Stephansson O. Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling design. BMJ 2015;351:h5585. [Ref.ID 99695]

13.

Anónimo. Influenza vaccine for 2015-2016. Med Lett Drugs Ther 2015;57:125-7. [Ref.ID 99652]

14.

Anónimo. Peramivir (Rapivab): an IV neuraminidase inhibitor for treatment of influenza. Med Lett Drugs Ther 2015;57:17-9. [Ref.ID 98855]

15.

Young K. Favipiravir shows some promise in early Ebola study. Journal Watch 2015:1. [Ref.ID 98771]

16.

Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 2015;385:1729-37. [Ref.ID 98765]

17.

Anónimo. Early estimates of seasonal influenza vaccine effectiveness — United States, January 2015. Morbidity and Mortality Weekly Report 2015;64:10-5. [Ref.ID 98711]

18.

Anónimo. FDA approves Rapivab to treat flu infection. FDA U.S. Food and Drug Administration 2014:1. [Ref.ID 98394]

19.

Sofair A, Chavey WE. 2014-15 flu vaccine not a perfect match to circulating viruses. Physician's First Watch 2014:5 de diciembre. [Ref.ID 98348]

20.

Bischoff-Ferrari HA, Meyer O. Comparative effectiveness of pharmacologic treatments to prevent fractures: is this all we need to know?. Ann Intern Med 2014;161:711-23. [Ref.ID 98329]